Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Boehringer and Lilly report positive data from Tradjenta trial

Boehringer and Lilly have reported that the CAROLINA trial met its primary endpoint of non-inferiority for Tradjenta. Credit: © Boehringer Ingelheim.



  • Boehringer, Lilly report positive data from CAROLINA trial of Tradjenta

Go Top